Second Coronavirus Vaccine Nearly 95 Percent Effective in Preliminary Study by Jon Blistein November 30, 2020 Biotech company Moderna will seek emergency use authorization from the FDA Share Share on Facebook Tweet Tweet on Twitter Pin it Pin on Pinterest
